Find your care
Theranostics provides therapy options for those with prostate cancer, neuroendocrine tumors, thyroid cancer and hyperactive thyroid glands.
The Theranostics process usually involves a diagnostic scan, a consult with a Nuclear Medicine physician and therapy with a radioactive drug.
There are currently four FDA-approved treatments:
- Lutathera for neuroendocrine tumors
- Pluvicto and Xofigo for prostate cancer
- I-131 for thyroid cancer and hyperactive thyroid glands